| | |
Gradientsc
|
---|
|
Status
|
(WHO)
| |
Insulin
|
C-peptide
|
---|
Women
| | | | | |
Population
|
NGTa
|
82.5%
|
Negatived
|
30.2%
|
65.3%
|
|
IGTb
|
17.5%
|
Positive
|
69.8%
|
34.7%
|
Classes
|
NGT
|
82.7%
|
Negative
|
70.4%
|
29.2%
|
|
IGT
|
17.3%
|
Positive
|
29.6%
|
70.8%
|
Men
| | | | | |
Population
|
NGT
|
72.8%
|
Negative
|
24.9%
|
55.2%
|
|
IGT
|
27.2%
|
Positive
|
75.1%
|
44.8%
|
Classes
|
NGT
|
81.1%
|
Negative
|
81.1%
|
41.0%
|
|
IGT
|
18.9%
|
Positive
|
18.9%
|
59.0%
|
- aNGT, normal glucose tolerance; IGT, impaired glucose tolerance. According to the WHO criteria (ref. 40)
- bIGT, defined as glucose at 0 minutes above 6.1 mmol/l and/or glucose at 120 minutes above 7.8 mmol/l
- cGradients calculated as the differnece between the 120 min and 30 min levels.
- dNegative: negative gradients; Positive: positive gradients